New therapeutic approaches for neurological diseases

Hermo Pharma Ltd. is a biopharmaceutical company focused on discovering and developing novel treatments for severe neurological diseases. Our research focus is on neurodegenerative diseases and on modulation of neuronal plasticity. Hermo Pharma Ltd. aims at developing novel disease-modifying treatments for amblyopia, Parkinson’s disease and Alzheimer’s disease.

RSS News Follow us on Twitter Watch us on YouTube

NEWS & PUBLICATIONS

16.04.13 Gene therapy with CDNF provides functional benefits in a rat model of Parkinson's disease
Bäck S, Peränen J, Galli E, Pulkkila P, Lonka-Nevalaita L, Tamminen T,...
Read more
12.04.13 Transformative healthcare - 2013 is a big year for Hermo Pharma
Helsinki Times recently interviewed CEO Juhani Lahdenperä about Hermo...
Read more